The World Anti-Doping Agency (WADA) today published its 2016 Testing Figures Report (2016 Report), which summarises the results of all the samples WADA-accredited laboratories analysed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2016.
A 0.9 percent decrease in the overall number of samples analyzed: 303,369 in 2015 to 300,565 in 2016.
A noteworthy increase in the number of Adverse Analytical Findings (AAF): 1.26 percent in 2015 (3,809 AAFs from 303,369 samples) to 1.60 percent in 2016 (4,822 AAFs from 300,565 samples).
About 60 percent of WADA-accredited laboratories saw an increase in the total number of samples.
A relative increase in the overall number of (non-Athlete Biological Passport) blood samples analyzed: 6.98 percent in 2015 (21,176 of 303,369) to 7.75 percent in 2016 (23,298 of 300,565).
An increase of 13 percent in the number of Athlete Biological Passport samples analyzed: 25,012 in 2015 to 28,173 in 2016.
The full report is available for download on the WADA website.